肾脏肿块的影像学评估与非手术治疗
本文综述肾脏肿块的非手术治疗选择,包括热消融、立体定向体部放疗和肾动脉栓塞,重点阐述各治疗后影像学表现的时间演变规律,以帮助放射科医生识别正常术后改变、并发症及局部肿瘤进展。
要点
- 热消融是小肾肿瘤可接受的替代治疗,美国国家综合癌症网络指南将其纳入T1a及部分T1b肾肿块的治疗策略。
- 立体定向体部放疗后影像学表现与热消融不同,需理解其时间演变以正确识别局部肿瘤进展。
- 肾动脉栓塞对肾血管平滑肌脂肪瘤安全有效,也可作为肾细胞癌的辅助或姑息治疗。
核心结论
- 随着肾脏肿块局部区域治疗日益普及,放射科医生在随访影像判读中责任更大,需基于对操作过程及影像表现的理解准确评估正常术后改变与肿瘤学结局。
研究设计与样本
- 本文为综述,纳入范围涵盖肾脏肿块热消融、立体定向体部放疗和肾动脉栓塞等非手术治疗方式及其影像学随访表现,原文未报告系统检索策略与文献纳入数量。
关键影像表现/征象
- 立体定向体部放疗后的影像学表现与热消融后不同,需理解其时间演变以正确识别局部肿瘤进展。
- 术后并发症和复发肿瘤可基于偏离预期病程的影像表现来识别。
诊断标准与关键数值
- 美国国家综合癌症网络指南将热消融列为T1a及部分T1b肾肿块的治疗策略。
- 肾动脉栓塞被认可为对肾血管平滑肌脂肪瘤安全有效。
临床应用与阅片要点
- 放射科医生判读随访影像时,应基于对操作过程的理解区分正常术后改变、并发症与复发肿瘤。
- 立体定向体部放疗后需掌握其影像学改变的时间演变规律,以正确识别局部肿瘤进展。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
In patients with renal masses, when intervention is warranted, partial nephrectomy is preferred when feasible, especially for T1 renal masses. Thermal ablation, however, has become an accepted alternative treatment of small renal neoplasms with excellent oncologic outcomes. The National Comprehensive Cancer Network guidelines include thermal ablation as a treatment strategy for managing T1a and select T1b masses. Other potential locoregional treatments for malignant and benign renal masses are emerging. Stereotactic body radiation therapy (SBRT) is gaining traction in the management of select localized renal masses and can be considered in patients who are not surgical candidates. Imaging findings after SBRT differ from those after thermal ablation. As this technique becomes more widely used, the temporal evolution of post-SBRT changes needs to be understood to correctly identify local tumor progression. Renal artery embolization is accepted as safe and effective for patients with renal angiomyolipoma. It can also be used in the management of renal cell carcinoma as an adjunct to definitive treatment or for palliation in advanced disease. With the growing acceptance of local-regional treatment of renal masses and the corresponding number of related patients undergoing surveillance and postablation imaging, the diagnostic radiologist will have greater responsibility in the appropriate interpretation of follow-up imaging to accurately assess normal postprocedural findings and define oncologic outcomes. Such interpretations should be based on understanding of the procedure and related imaging findings, both acutely and in the years after treatment. Procedural complications and recurrent tumor are identifiable based on deviations from the expected course. ©RSNA, 2024 Supplemental material is available for this article.
引用
- Jorgenson LC, Navin PJ, Adamo D, et al. Imaging and Nonsurgical Management of Renal Masses. Radiographics. 2025. PMID: 39700039. doi:10.1148/rg.240093
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。